ST. AUGUSTINE, FL – Carlisle Interconnect Technologies has acquired MicroConnex, a privately held manufacturer of flex circuits for the medical and test and measurement markets.

MicroConnex will operate under CIT’s Medical Technologies Business Unit known as Carlisle Medical Technologies (CMT), a leader in the medical device cable and interconnect market.

Other terms of the acquisition were not disclosed.

This acquisition aligns with CMT’s focus on expanding its platform of advanced technology capabilities to further enable highly-integrated devices that support critical and cost-effective performance requirements.

“With this acquisition, we are steps closer to fulfilling CMT’s vision to be the industry leader in the design, development and vertically-integrated manufacturing of advanced medical device solutions,” Constantine Davlantes, VP and GM of Carlisle Medical Technologies. “Not only is CMT a leader in providing innovative solutions, but we’re backed by world-class quality and customer support.”

MicroConnex was founded by Thomas Clary and Scott Corbett in 1995 as MicroSound Systems. In 2000, the firm was took on outside investors and moved to Snoqualmie, WA, where it changed its name to MicroConnex to reflect the shift from R&D services to commercial flexible circuits fabrication and laser micromachining services.

“Our team is excited to partner with CIT to continue our focus on advanced technologies,” said Paul Henwood, president and CEO of MicroConnex. “The combination of MicroConnex and CIT will open new doors for MicroConnex to drive growth, innovation and cutting-edge product solutions within the Medical and Test & Measurement markets. CIT is a great cultural fit with MicroConnex and we are excited to begin the next chapter in our company’s history.”

MicroConnex builds on CIT’s recent acquisition of Redgroup, a company specializing in design and development of complex catheter technologies. Both acquisitions broaden Carlisle IT’s expertise and the value the company delivers to OEM customers.